The DOI matches its Crossref record.
Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin
Abstract
Quercetin, a widely distributed bioflavonoid, has been shown to induce growth inhibition in certain cancer cell types. In the present study we have pursued the mechanism of growth inhibition in MCF-7 human breast cancer cells. Quercetin treatment resulted in the accumulation of cells specifically at G2/M phase of the cell cycle. Mitotic index measured by MPM2 staining clearly showed that cells were transiently accumulated in M phase, 24 h after treatment. The transient M phase accumulation was accompanied by a transient increase in the levels of cyclin B1 and Cdc2 kinase activity. However, 24 h or longer treatment caused a marked accumulation of cells in G2 instead of M phase. Levels of cyclin B1 and cyclin B1-associated Cdc2 kinase activity were also decreased. We also found that quercetin markedly increased Cdk-inhibitor p21CIP1/WAF1 protein level after treatment for 48 h or longer, and the induction of p21CIP1/WAF1 increased its association with Cdc2-cyclin B1 complex, however, up-regulation of p53 by quercetin was not observed. Quercetin also induced significant apoptosis in MCF-7 cells in addition to cell cycle arrest, and the induction of apoptosis was markedly blocked by antisense p21CIP1/WAF1 expression. The present data, therefore, demonstrate that a flavonoid quercetin induces growth inhibition in the human breast carcinoma cell line MCF-7 through at least two different mechanisms; by inhibiting cell cycle progression through transient M phase accumulation and subsequent G2 arrest, and by inducing apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Flavonoids: Promising anticancer agents
Ren, W., Qiao, Z., Wang, H., Zhu, L., & Zhang, L. (2003) · Medicinal Research Reviews · doi:10.1002/med.10033 · Cited by 1,150
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
Flavonoids: A versatile source of anticancer drugs
Sharma, N., Dobhal, M., Joshi, Y., & Chahar, M. (2011) · Pharmacognosy Reviews · doi:10.4103/0973-7847.79093 · Cited by 551
Minor components of pulses and their potential impact on human health
Campos-Vega, R., Loarca-Piña, G., & Oomah, B. D. (2010) · Food Research International · doi:10.1016/j.foodres.2009.09.004 · Cited by 530
Srivastava, S., Somasagara, R. R., Hegde, M., Nishana, M., Tadi, S. K., Srivastava, M., Choudhary, B., & Raghavan, S. C. (2016) · Scientific Reports · doi:10.1038/srep24049 · Cited by 483
Brusselmans, K., Vrolix, R., Verhoeven, G., & Swinnen, J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408177200 · Cited by 474
Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseases
Neto, C. C. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600279 · Cited by 460
Review: Dietary Flavonoids and Cancer Risk: Evidence From Human Population Studies
Neuhouser, M. L. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc5001_1 · Cited by 449
A Review of the Effects and Mechanisms of Polyphenolics in Cancer
Nichenametla, S. N., Taruscio, T. G., Barney, D. L., & Exon, J. H. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390591000541 · Cited by 444
Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progression
Jeong, J., An, J. Y., Kwon, Y. T., Rhee, J. G., & Lee, Y. J. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21977 · Cited by 380
Self-citationSpencer, J. P. E., Rice-Evans, C., & Williams, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305063200 · Cited by 349
Chou, C.-C., Yang, J.-S., Lu, H.-F., Ip, S.-W., Lo, C., Wu, C.-C., Lin, J.-P., Tang, N.-Y., Chung, J.-G., Chou, M.-J., et al. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0808-y · Cited by 310
Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells
Vafadar, A., Shabaninejad, Z., Movahedpour, A., Fallahi, F., Taghavipour, M., Ghasemi, Y., Akbari, M., Shafiee, A., Hajighadimi, S., Moradizarmehri, S., et al. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00397-0 · Cited by 296
Pappas, E., & Schaich, K. M. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802145377 · Cited by 301
Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies
Neto, C. C. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.186s · Cited by 294
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Kashyap, D., Garg, V. K., Tuli, H. S., Yerer, M. B., Sak, K., Sharma, A. K., Kumar, M., Aggarwal, V., & Sandhu, S. S. (2019) · Biomolecules · doi:10.3390/biom9050174 · Cited by 285
Wang, L., Lee, I.-M., Zhang, S. M., Blumberg, J. B., Buring, J. E., & Sesso, H. D. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26913 · Cited by 285
Mertens-Talcott, S. U., & Percival, S. S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.06.007 · Cited by 282
Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets
Asgharian, P., Tazekand, A. P., Hosseini, K., Forouhandeh, H., Ghasemnejad, T., Ranjbar, M., Hasan, M., Kumar, M., Beirami, S. M., Tarhriz, V., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02677-w · Cited by 274
Chien, S.-Y., Wu, Y.-C., Chung, J.-G., Yang, J.-S., Lu, H.-F., Tsou, M.-F., Wood, W., Kuo, S.-J., & Chen, D.-R. (2009) · Human & Experimental Toxicology · doi:10.1177/0960327109107002 · Cited by 269
Potential synergism of natural products in the treatment of cancer
HemaIswarya, S., & Doble, M. (2006) · Phytotherapy Research · doi:10.1002/ptr.1841 · Cited by 266
HSP70 Multi-Functionality in Cancer
Albakova, Z., Armeev, G. A., Kanevskiy, L. M., Kovalenko, E. I., & Sapozhnikov, A. M. (2020) · Cells · doi:10.3390/cells9030587 · Cited by 265
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
Antioxidants as treatment for neurodegenerative disorders
Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 252
Wätjen, W., Michels, G., Steffan, B., Niering, P., Chovolou, Y., Kampkötter, A., Tran-Thi, Q.-H., Proksch, P., & Kahl, R. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.525 · Cited by 240
A Review of Dietary Phytochemicals and Their Relation to Oxidative Stress and Human Diseases
Guan, R., Van Le, Q., Yang, H., Zhang, D., Gu, H., Yang, Y., Sonne, C., Lam, S. S., Zhong, J., Jianguang, Z., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.129499 · Cited by 169
Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Neto, V. M., & Abreu, J. G. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.003 · Cited by 125
Metadata
- Authors
- Choi, J.-A., Kim, J.-Y., Lee, J.-Y., Kang, C.-M., Kwon, H.-J., Yoo, Y.-D., Kim, T.-W., Lee, Y.-S., & Lee, S.-J.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2001-10-01
- Volume
- 19
- Issue
- 4
- Pages
- 837-44
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W1977101823
- Cited by
- 363
- References
- 0
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.